Peyronie's disease: options in pharmacologic management

Area of Science:

• Urology
• Andrology
• Connective Tissue Diseases

Background:

• Peyronie's disease involves penile plaque formation, leading to pain, curvature, and erectile dysfunction.
• Surgical intervention is the traditional treatment for penile curvature, but medical therapies offer less invasive alternatives.
• Previous oral therapies showed limited efficacy, prompting investigation into alternative drug delivery methods.

Purpose of the Study:

• To review current and emerging medical treatments for Peyronie's disease.
• To evaluate the efficacy of intraplaque injections and topical therapies.
• To highlight the need for further controlled trials and research into disease pathophysiology.

Main Methods:

• Review of existing literature on Peyronie's disease treatments.
• Analysis of studies on intraplaque injections (verapamil, interferon) and topical verapamil.
• Examination of the role of iontophoresis in enhancing drug delivery.

Main Results:

• Intraplaque injections demonstrate mild-to-moderate benefits in stabilizing Peyronie's disease.
• Topical verapamil studies yield conflicting results.
• Iontophoresis is emerging as a method to improve drug delivery for Peyronie's disease.

Conclusions:

• Medical therapies, particularly injections, offer potential alternatives to surgery for Peyronie's disease.
• Controlled trials are essential to determine optimal dosing and efficacy of current treatments.
• Understanding the pathophysiology of Peyronie's disease is crucial for developing novel therapeutic strategies.